SCIGEN PTE. LTD. – Trademark Portfolio

Entity Type: 24

SCIGEN PTE. LTD. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include EVIVE and EVIVE BIOTECH.

150 Beach Road

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

SCIGEN PTE. LTD.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (4 filings)

Scientific and technological services; industrial analysis and research services

10
Medical Apparatus (4 filings)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does SCIGEN PTE. LTD. have?

SCIGEN PTE. LTD. has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.

What trademark classes does SCIGEN PTE. LTD. file in?

SCIGEN PTE. LTD. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.

What are SCIGEN PTE. LTD.'s most well-known trademarks?

SCIGEN PTE. LTD.'s registered trademark portfolio includes well-known marks such as EVIVE and EVIVE BIOTECH. These are among 4 currently registered trademarks in the portfolio.

What is SCIGEN PTE. LTD.'s trademark registration success rate?

SCIGEN PTE. LTD. has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.